These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23520132)

  • 21. Relation between carotid intima-media thickness and left ventricular mass in type 1 diabetes mellitus (from the Epidemiology of Diabetes Interventions and Complications [EDIC] Study).
    Chahal H; Backlund JY; Cleary PA; Lachin JM; Polak JF; Lima JA; Bluemke DA;
    Am J Cardiol; 2012 Nov; 110(10):1534-40. PubMed ID: 22884107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
    Polak JF; Backlund JY; Cleary PA; Harrington AP; O'Leary DH; Lachin JM; Nathan DM;
    Diabetes; 2011 Feb; 60(2):607-13. PubMed ID: 21270271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Factors for Longitudinal Resting Heart Rate and Its Associations With Cardiovascular Outcomes in the DCCT/EDIC Study.
    Keshavarzi S; Braffett BH; Pop-Busui R; Orchard TJ; Soliman EZ; Lorenzi GM; Barnie A; Karger AB; Gubitosi-Klug RA; Dagogo-Jack S; Paterson AD;
    Diabetes Care; 2021 May; 44(5):1125-1132. PubMed ID: 33632724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.
    Nathan DM;
    Diabetes Care; 2014; 37(1):9-16. PubMed ID: 24356592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study.
    Bebu I; Schade D; Braffett B; Kosiborod M; Lopes-Virella M; Soliman EZ; Herman WH; Bluemke DA; Wallia A; Orchard T; Lachin JM;
    Diabetes Care; 2020 Apr; 43(4):867-874. PubMed ID: 32001614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
    White NH; Sun W; Cleary PA; Danis RP; Davis MD; Hainsworth DP; Hubbard LD; Lachin JM; Nathan DM
    Arch Ophthalmol; 2008 Dec; 126(12):1707-15. PubMed ID: 19064853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus.
    Bharucha AE; Batey-Schaefer B; Cleary PA; Murray JA; Cowie C; Lorenzi G; Driscoll M; Harth J; Larkin M; Christofi M; Bayless M; Wimmergren N; Herman W; Whitehouse F; Jones K; Kruger D; Martin C; Ziegler G; Zinsmeister AR; Nathan DM;
    Gastroenterology; 2015 Aug; 149(2):330-9. PubMed ID: 25980755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes: The DCCT/EDIC Trials.
    Budoff M; Backlund JC; Bluemke DA; Polak J; Bebu I; Schade D; Strowig S; Raskin P; Lachin JM;
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 2):1341-1349. PubMed ID: 30878435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
    Albers JW; Herman WH; Pop-Busui R; Feldman EL; Martin CL; Cleary PA; Waberski BH; Lachin JM;
    Diabetes Care; 2010 May; 33(5):1090-6. PubMed ID: 20150297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coprogression of Cardiovascular Risk Factors in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study.
    Writing Group for the DCCT/EDIC Research Group
    Diabetes Care; 2016 Sep; 39(9):1621-30. PubMed ID: 27436274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality in Type 1 Diabetes in the DCCT/EDIC Versus the General Population.
    Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group
    Diabetes Care; 2016 Aug; 39(8):1378-83. PubMed ID: 27411699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study.
    Gubitosi-Klug RA; Braffett BH; White NH; Sherwin RS; Service FJ; Lachin JM; Tamborlane WV;
    Diabetes Care; 2017 Aug; 40(8):1010-1016. PubMed ID: 28550194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.
    Genuth S
    Endocr Pract; 2006; 12 Suppl 1():34-41. PubMed ID: 16627378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Realising the long-term promise of insulin therapy: the DCCT/EDIC study.
    Nathan DM
    Diabetologia; 2021 May; 64(5):1049-1058. PubMed ID: 33550441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone and cardiac mass and function in men with type 1 diabetes in the Epidemiology of Diabetes Interventions and Complications Study (EDIC).
    Kim C; Bebu I; Braffett B; Cleary PA; Arends V; Steffes M; Wessells H; Orchard T; Sarma AV;
    Clin Endocrinol (Oxf); 2016 May; 84(5):693-9. PubMed ID: 26641212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.
    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
    JAMA; 2002 May; 287(19):2563-9. PubMed ID: 12020338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Volume-time curve of cardiac magnetic resonance assessed left ventricular dysfunction in coronary artery disease patients with type 2 diabetes mellitus.
    Xu HY; Yang ZG; Guo YK; Shi K; Liu X; Zhang Q; Jiang L; Xie LJ
    BMC Cardiovasc Disord; 2017 Jun; 17(1):145. PubMed ID: 28583071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mediation of the Effect of Glycemia on the Risk of CVD Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.
    Bebu I; Braffett BH; Orchard TJ; Lorenzi GM; Lachin JM;
    Diabetes Care; 2019 Jul; 42(7):1284-1289. PubMed ID: 30894365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort.
    Chen Z; Miao F; Paterson AD; Lachin JM; Zhang L; Schones DE; Wu X; Wang J; Tompkins JD; Genuth S; Braffett BH; Riggs AD; ; Natarajan R
    Proc Natl Acad Sci U S A; 2016 May; 113(21):E3002-11. PubMed ID: 27162351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.